KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Work In Process: 2023-2025

Historic Work In Process for Aurinia Pharmaceuticals (AUPH) over the last 1 years, with Sep 2025 value amounting to $42.6 million.

  • Aurinia Pharmaceuticals' Work In Process was N/A to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.6 million, marking a year-over-year change of. This contributed to the annual value of $36.6 million for FY2024, which is 2.01% down from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Work In Process of $42.6 million as of Q3 2025, which was down 1.22% from $43.2 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Work In Process registered a high of $43.2 million during Q2 2025, and its lowest value of $36.6 million during Q4 2024.
  • Over the past 3 years, Aurinia Pharmaceuticals' median Work In Process value was $41.7 million (recorded in 2025), while the average stood at $40.3 million.
  • Data for Aurinia Pharmaceuticals' Work In Process shows a maximum YoY dropped of 2.01% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Aurinia Pharmaceuticals' Work In Process stood at $37.4 million in 2023, then dropped by 2.01% to $36.6 million in 2024, then reached $42.6 million in 2025.
  • Its Work In Process stands at $42.6 million for Q3 2025, versus $43.2 million for Q2 2025 and $41.7 million for Q1 2025.